- Home
- RCUS vs BLSH Comparison
RCUS vs BLSH Comparison
Compare RCUS & BLSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | BLSH |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | Cayman Islands |
| Employees | 601 | 414 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | RCUS | BLSH |
|---|---|---|
| Price | $28.53 | $23.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $31.90 | ★ $51.91 |
| AVG Volume (30 Days) | 1.3M | ★ 1.3M |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | $64.30 |
| Revenue Next Year | $45.62 | $17.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.84 | $21.76 |
| 52 Week High | $31.74 | $74.98 |
Technical Indicators
Market Signals| Indicator | RCUS | BLSH |
|---|---|---|
| Relative Strength Index (RSI) | 51.38 | 44.59 |
| Support Level | $20.20 | $21.76 |
| Resistance Level | $28.72 | $26.51 |
| Average True Range (ATR) | 1.33 | 1.48 |
| MACD | -0.16 | 0.30 |
| Stochastic Oscillator | 50.83 | 38.21 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About BLSH Bullish Ordinary Shares
Bullish is an institutionally focused global digital asset platform focused on providing market infrastructure and information services. Its objective is to provide mission critical products and services that are designed to help institutions grow their businesses, empower individual investors, and drive the adoption of stablecoins, digital assets, and blockchain technology. It expanded its product offering to provide trusted insights, authoritative news, data, indices and transparent analysis to the digital assets industry while facilitating partnerships, investment opportunities, and community engagement through its flagship Consensus conference.